Belgium startup funding in H2 2021
European tech funding raised by Belgium startups during H2 2021.
In H2 2021, 42 startups in Belgium closed 44 funding rounds and raised €667M in equity funding (excluding debt and grants), up 117.2% versus H2 2020. Debt rounds added €20M. Software was the most active sector, and PMV was the most active investor. Data as of 20 Nov 2026.
Equity funding
€667M
+117.2% vs H2 2020 · excl. debt & grants · +€20M debt
Funding rounds
44
+2.3% vs H2 2020
Companies
42
Top sector
Software
Rank in Europe
#14
1.1% of European funding
Debt financing
€20M
2.9% of total
Top-10 round share
85.1%
of disclosed capital
Rounds ≥ €100M
2
Funding by month
€ raised vs rounds, by monthBelgium — funding by month, H2 2021 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jul | €222M | 9 |
| Aug | €15M | 2 |
| Sep | €31M | 6 |
| Oct | €29M | 6 |
| Nov | €240M | 6 |
| Dec | €152M | 15 |
Top sectors
by € raisedBelgium — top sectors by capital, H2 2021 — interactive chart.
Data table
| Belgium — top sectors by capital, H2 2021 | |
|---|---|
| Software | €416M |
| Healthtech | €174M |
| Cybersecurity | €26M |
| Consumer | €19M |
| Semiconductors | €14M |
| Edtech | €13M |
| Fintech | €12M |
| Marketing | €12M |
Stage mix
by € raisedBelgium — stage mix, H2 2021 — interactive chart.
Data table
| Belgium — stage mix, H2 2021 | |
|---|---|
| Other | €373M |
| Series D+ | €216M |
| Series B | €66M |
| Debt | €20M |
| Series A | €6.2M |
| Early VC | €3.0M |
| Seed | €2.2M |
| Grant | €1.8M |
Exits & M&A
21 Acquisition21 exits · €1.8B disclosed.
| VOO | Acquisition | Dec 2021 | €1.4B |
| Oqton | Acquisition | Sep 2021 | €152M |
| Emakina | Acquisition | Nov 2021 | €120M |
| Connective | Acquisition | Nov 2021 | €70M |
| iController | Acquisition | Oct 2021 | €50M |
| Acapela Group | Acquisition | Nov 2021 | €9.8M |
Top deals
largest disclosed rounds in H2 2021| Company | Stage | Date | Amount |
|---|---|---|---|
| Collibra | Series D+ | Nov 2021 | €216M |
| odoo | Other | Jul 2021 | €180M |
| EyeD Pharma | Other | Dec 2021 | €45M |
| Celyad Oncology | Other | Dec 2021 | €29M |
| itsme | Other | Jul 2021 | €25M |
| Midiagnostics | Debt | Dec 2021 | €20M |
| Novadip Biosciences | Series B | Nov 2021 | €19M |
| GOODID | Other | Dec 2021 | €19M |
| PDC*line Pharma | Series B | Dec 2021 | €18M |
| Rejuvenate Boimed | Series B | Oct 2021 | €16M |
| Spectricity | Series B | Aug 2021 | €14M |
| MySkillCamp | Other | Sep 2021 | €12M |
| Sortlist | Other | Sep 2021 | €11M |
| Sunrise | Other | Dec 2021 | €6.5M |
| Azalea Vision | Series A | Jul 2021 | €6.2M |
Top investors
most active in H2 2021, by deal count- PMV7 deals
- Sambrinvest2 deals
- VLAIO2 deals
- SRIW2 deals
- imec.istart2 deals
- imec.xpand2 deals
- Buysse & Partners1 deals
- BNP Paribas1 deals
- Altinvestor Connect Ventures1 deals
- Brain Asset Management1 deals